Prev：Multiple comparisons of three different sources of biomaterials in the application of tumor tissue engineering in vitro and in vivo(KTE62728-4)
Next：Multiple protease-activated probody-drug conjugates for treating CD147-positive ovarian cancer with limited toxicity(BMU106-10.5)
